Literature DB >> 34376262

Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico.

Miguel Arce Rentería1, Jennifer J Manly1, Jet M J Vonk1,2, Silvia Mejia Arango3, Alejandra Michaels Obregon4, Rafael Samper-Ternent4,5, Rebeca Wong4, Sandra Barral1, Giuseppe Tosto1.   

Abstract

OBJECTIVE: To estimate the prevalence of mild cognitive impairment (MCI) and its subtypes and investigate the impact of midlife cardiovascular risk factors on late-life MCI among the aging Mexican population.
METHOD: Analyses included a sample of non-demented adults over the age of 55 living in both urban and rural areas of Mexico (N = 1807). MCI diagnosis was assigned based on a comprehensive cognitive assessment assessing the domains of memory, executive functioning, language, and visuospatial ability. The normative sample was selected by means of the robust norms approach. Cognitive impairment was defined by a 1.5-SD cut-off per cognitive domain using normative corrections for age, years of education, and sex. Risk factors included age, education, sex, rurality, depression, insurance status, workforce status, hypertension, diabetes, stroke, and heart disease.
RESULTS: The prevalence of amnestic MCI was 5.9%. Other MCI subtypes ranged from 4.2% to 7.7%. MCI with and without memory impairment was associated with older age (OR = 1.01 [1.01, 1.05]; OR = 1.03 [1.01, 1.04], respectively) and residing in rural areas (OR = 1.49 [1.08, 2.06]; OR = 1.35 [1.03, 1.77], respectively). Depression (OR = 1.07 [1.02, 1.12]), diabetes (OR = 1.37 [1.03, 1.82]), and years of education (OR = 0.94 [0.91, 0.97]) were associated with MCI without memory impairment. Midlife CVD increased the odds of MCI in late-life (OR = 1.76 [1.19, 2.59], which was driven by both midlife hypertension and diabetes (OR = 1.70 [1.18, 2.44]; OR = 1.88 [1.19, 2.97], respectively).
CONCLUSIONS: Older age, depression, low education, rurality, and midlife hypertension and diabetes were associated with higher risk of late-life MCI among older adults in Mexico. Our findings suggest that the causes of cognitive impairment are multifactorial and vary by MCI subtype.

Entities:  

Keywords:  Cognitive aging; MHAS; Mex-Cog; Mexican population; Mild cognitive impairment; Neuropsychology

Mesh:

Year:  2021        PMID: 34376262      PMCID: PMC8831650          DOI: 10.1017/S1355617721000539

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  50 in total

1.  Diagnosis of dementia from the history and aetiology schedule.

Authors:  M E Dewey; J R Copeland
Journal:  Int J Geriatr Psychiatry       Date:  2001-09       Impact factor: 3.485

2.  Midlife cardiovascular risk factors and risk of dementia in late life.

Authors:  R A Whitmer; S Sidney; J Selby; S Claiborne Johnston; K Yaffe
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

Review 3.  Mild cognitive impairment as a clinical entity and treatment target.

Authors:  Ronald C Petersen; John C Morris
Journal:  Arch Neurol       Date:  2005-07

4.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

5.  Cohort Profile: The Mexican Health and Aging Study (MHAS).

Authors:  Rebeca Wong; Alejandra Michaels-Obregon; Alberto Palloni
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

6.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Authors:  Mark W Bondi; Emily C Edmonds; Amy J Jak; Lindsay R Clark; Lisa Delano-Wood; Carrie R McDonald; Daniel A Nation; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging.

Authors:  R C Petersen; R O Roberts; D S Knopman; Y E Geda; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

8.  Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.

Authors:  M Kivipelto; E L Helkala; T Hänninen; M P Laakso; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

9.  Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study.

Authors:  Antonio Di Carlo; Marzia Baldereschi; Luigi Amaducci; Vito Lepore; Laura Bracco; Stefania Maggi; Salvatore Bonaiuto; Egle Perissinotto; Guglielmo Scarlato; Gino Farchi; Domenico Inzitari
Journal:  J Am Geriatr Soc       Date:  2002-01       Impact factor: 5.562

10.  Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology.

Authors:  Lisa Delano-Wood; Mark W Bondi; Joshua Sacco; Norm Abeles; Amy J Jak; David J Libon; Andrea Bozoki
Journal:  J Int Neuropsychol Soc       Date:  2009-11       Impact factor: 2.892

View more
  2 in total

1.  The complex burden of determining prevalence rates of mild cognitive impairment: A systematic review.

Authors:  Maria Casagrande; Giulia Marselli; Francesca Agostini; Giuseppe Forte; Francesca Favieri; Angela Guarino
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

2.  Rural/urban dwelling across the life-course and late-life cognitive ability in Mexico.

Authors:  Joseph L Saenz; Brian Downer; Marc A Garcia; Rebeca Wong
Journal:  SSM Popul Health       Date:  2022-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.